Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

HIMS

Live52w low +65.0%

Annual Quarterly

Core line items from HIMS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Log in Get Started

Annual Quarterly

Entity: HIMS & HERS HEALTH, INC.·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-08-03	Q1 2026 2026-03-31	Annual 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30
Revenue	$698.96M	$608.10M	$2.35B	$1.73B	$1.13B
Operating Income	Not available	$-78.32M	$105.61M	$96.43M	$84.62M
Net Income	Not available	$-92.11M	$128.37M	$107.76M	$42.51M
EPS (Diluted)	$0.10	$-0.40	$0.51	$0.43	$0.37
Total Assets	Not available	$2.27B	$2.15B	$2.23B	$1.88B
Total Liabilities	Not available	$1.82B	$1.61B	$1.65B	$1.31B
Cash & Equivalents	Not available	$222.27M	$228.62M	$345.78M	$1.12B
Free Cash Flow OCF − CapEx	Not available	$53.06M	$57.41M	$59.99M	$-19.43M
Shares Outstanding	Not available	228.36M	258.23M	255.55M	251.89M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.

Core line items from HIMS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w low +65.0%

Entity: HIMS & HERS HEALTH, INC.·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-08-03	Q1 2026 2026-03-31	Annual 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30
Revenue	$698.96M	$608.10M	$2.35B	$1.73B	$1.13B
Operating Income	Not available	$-78.32M	$105.61M	$96.43M	$84.62M
Net Income	Not available	$-92.11M	$128.37M	$107.76M	$42.51M
EPS (Diluted)	$0.10	$-0.40	$0.51	$0.43	$0.37
Total Assets	Not available	$2.27B	$2.15B	$2.23B	$1.88B
Total Liabilities	Not available	$1.82B	$1.61B	$1.65B	$1.31B
Cash & Equivalents	Not available	$222.27M	$228.62M	$345.78M	$1.12B
Free Cash Flow OCF − CapEx	Not available	$53.06M	$57.41M	$59.99M	$-19.43M
Shares Outstanding	Not available	228.36M	258.23M	255.55M	251.89M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.